Patent expiration risk for total worldwide global Rx drug revenue 2024-2030
- statista.com
Updated Nov 22, 2024
Share
Facebook
Twitter
EmailClick to copy linkLink copiedCiteMatej Mikulic (2024). Patent expiration risk for total worldwide global Rx drug revenue 2024-2030 [Dataset]. https://www.statista.com/topics/1764/global-pharmaceutical-industry/Dataset updatedNov 22, 2024AuthorsMatej MikulicDescriptionThis statistic depicts the total prescription drug revenue worldwide that is at risk due to patent expiration from 2024 to 2030. In 2028, the industry is expected to have 100 billion U.S. dollars in prescription drug sales worldwide at risk due to patent expiration. After the expiration of patent protection, other companies are allowed to make cheaper generics of the originally branded drug.
Patent expiration risk for total worldwide global Rx drug revenue 2025-2030
- statista.com
- tokrwards.com
Updated Sep 15, 2025ShareFacebookTwitterEmailClick to copy linkLink copiedCiteStatista (2025). Patent expiration risk for total worldwide global Rx drug revenue 2025-2030 [Dataset]. https://www.statista.com/statistics/309404/global-total-prescription-drug-revenue-at-risk-from-patent-expiration/Dataset updatedSep 15, 2025Area coveredWorldwideDescriptionThis statistic depicts the total prescription drug revenue worldwide that is at risk due to patent expiration from 2025 to 2030. In 2028, the industry is expected to have over *** billion U.S. dollars in prescription drug sales worldwide at risk due to patent expiration. After the expiration of patent protection, other companies are allowed to make cheaper generics of the originally branded drug.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
FacebookTwitterEmailPatent expiration risk for total worldwide global Rx drug revenue 2024-2030
This statistic depicts the total prescription drug revenue worldwide that is at risk due to patent expiration from 2024 to 2030. In 2028, the industry is expected to have 100 billion U.S. dollars in prescription drug sales worldwide at risk due to patent expiration. After the expiration of patent protection, other companies are allowed to make cheaper generics of the originally branded drug.